BCR/ABL, p210, MRNA Detection Monitoring
GTR Test Accession: Help GTR000613426.2
CAP
INHERITED DISEASECANCERHEMATOLOGY ... View more
Last updated in GTR: 2024-10-31
Last annual review date for the lab: 2024-10-24 LinkOut
At a Glance
Monitoring
Acute lymphoid leukemia; Chronic myelogenous leukemia, BCR-ABL1 positive
Genes (2): Help
ABL1 (9q34.12); BCR (22q11.23)
Molecular Genetics - Targeted variant analysis: RT-ddPCR
Individuals with BCR-ABL1 p210 variant positive chronic myeloid leukemia or …
Not provided
Not provided
Ordering Information
Offered by: Help
Sanford Medical Genetics Laboratory
View lab's test page
Test short name: Help
BCR/ABL
Manufacturer's name: Help
QXDx BCR-ABL %IS Kit from Bio-Rad
Specimen Source: Help
  • Bone marrow
  • Peripheral (whole) blood
Who can order: Help
  • Health Care Provider
Test Order Code: Help
LBOR0011
CPT codes: Help
**AMA CPT codes notice
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order: Help
Call Sanford Client support at (605) 328-5493
Order URL
Test service: Help
Monitoring
Test development: Help
Modified FDA (has FDA-reviewed entry, but with lab modifications/field changes)
Informed consent required: Help
Based on applicable state law
Test strategy: Help
BCR::ABL1, p210 fusion transcripts are quantified for monitoring of patients with BCR::ABL1 positive leukemia
Pre-test genetic counseling required: Help
No
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 2
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 2
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 1
Method Category Help
Test method Help
Instrument *
Targeted variant analysis
RT-ddPCR
* Instrument: Not provided
Clinical Information
Test purpose: Help
Monitoring
Target population: Help
Individuals with BCR-ABL1 p210 variant positive chronic myeloid leukemia or acute myeloid leukemia.
Recommended fields not provided:
Technical Information
Test Procedure: Help
Digital droplet PCR to quantify BCR::ABL1 copies. Reported as a percentage of the number of ABL copes and adjusted to match the international scale (IS) to report the %IS. The %IS is also converted into a molecular response (MR) which is the log reduction of the current %IS from 100% … View more
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
Limit of detection: MR4.7 (95% confidence). Sensitivity: 97.30%. Specificity: 89.47%.
Assay limitations: Help
This assay will not detect BCR::ABL e1a2 (p190), e19a2 (p230), or other rare transcripts. It is intended for monitoring patients with a BCR::ABL1 p210 positive hematologic neoplasm. The results should be interpreted in combination with all other clinical laboratory findings.
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
Yes

Method used for proficiency testing: Help
Formal PT program

PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Not provided
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.